- UnitedHealth CEO estimates one-third of Americans could be impacted by Change Healthcare cyberattackon May 1, 2024 at 9:01 pm
UnitedHealth CEO estimates that data from one-third of Americans could have been compromised in the Change Healthcare cyberattack.
- UnitedHealth CEO tells lawmakers the company paid hackers a $22 million ransomon May 1, 2024 at 8:41 pm
Senators questioned UnitedHealth Group CEO Andrew Witty on Wednesday about a cyberattack on its subsidiary Change Healthcare.
- Johnson & Johnson to pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.on May 1, 2024 at 8:23 pm
The deal would allow J&J to resolve the lawsuits through a third bankruptcy filing of a subsidiary company, LTL Management.
- CVS shares plummet as health company slashes profit outlook on higher medical costson May 1, 2024 at 8:19 pm
CVS and other insurers have seen medical costs spike as many Medicare Advantage patients return to hospitals to undergo procedures they delayed during Covid.
- Pfizer beats earnings estimates, raises outlook on cost cuts and smaller-than-feared drop in Covid drug saleson May 1, 2024 at 8:18 pm
The pharmaceutical giant's quarterly results also benefited from a smaller-than-feared drop in sales for its Covid antiviral pill Paxlovid.
- Eli Lilly assures investors it can overcome the high-quality problem of too much demandon May 1, 2024 at 3:51 pm
The world's most valuable drugmaker hiked its full-year sales and profit guidance, despite missing lighter-than-expected first-quarter revenue.
- Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successorson May 1, 2024 at 1:31 pm
AbbVie has two successors that could offset the losses from its blockbuster drug Humira. Meanwhile, UnitedHealth Group's CEO will testify on Capitol Hill.
- Cyberattack on UnitedHealth firm forces doctors to dig into personal savings to stay afloaton April 30, 2024 at 8:08 pm
Many doctors have been left without a way to get paid for their services.
- FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempicon April 30, 2024 at 7:41 pm
The agency sent letters to Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Covis Pharma, GlaxoSmithKline, Novartis, Teva Pharmaceuticals, among others.
- Jim Cramer says GE Healthcare's unwarranted post-earnings plunge is a buying opportunityon April 30, 2024 at 6:35 pm
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
Click Advertiser ♥